Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379425 · ClinicalTrials.gov registry record · Phase 4
Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries
A Phase 4 study of Pain, Postoperative and Postoperative Pain, Acute, sponsored by Northwell Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06379425: Recruiting Phase 4 study of Pain, Postoperative and Postoperative Pain, Acute, sponsored by Northwell Health.
NCT06379425 is a Phase 4 study of Pain, Postoperative and Postoperative Pain, Acute that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 70 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06379425, a Phase 4 study of Pain, Postoperative and Postoperative Pain, Acute, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a double-arm randomized control trial evaluating the impact of preoperative opioid-free analgesia on time to trial of void in ambulatory urogynecologic surgeries. The investigators hypothesize that receipt of acetaminophen, celecoxib and gabapentin preoperatively versus acetaminophen alone will reduce the time to trial of void in patients undergoing same-day minor urogynecologic procedures.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Celecoxib
- DRUG Gabapentin
Study Locations (1)
New York
- Northwell Health South Shore Surgery Center - Bay Shore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2026-03-01 |
| Phase | Phase 4 |
What NCT06379425 shows while recruiting
NCT06379425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen is the first listed.
NCT06379425 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06379425 about?
NCT06379425 is a clinical study titled "Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries". This is a double-arm randomized control trial evaluating the impact of preoperative opioid-free analgesia on time to trial of void in ambulatory urogynecologic surgeries. The investigators hypothesize that receipt of acetaminophen, celecoxib and gabapentin preoperatively versus acetaminophen alone w...
What is the current status of trial NCT06379425?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2024-03-01. Estimated completion is 2026-03-01.
What conditions does trial NCT06379425 study?
This clinical trial studies the following conditions: Pain, Postoperative, Postoperative Pain, Acute.
What interventions are being tested in trial NCT06379425?
The interventions under investigation include: Acetaminophen (DRUG), Celecoxib (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT06379425?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06379425 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06379425's enrollment target sits among peer trials
70 72nd of 113 higher than 42 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI